Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model

J Dermatol Sci. 2020 Feb;97(2):161-164. doi: 10.1016/j.jdermsci.2019.12.008. Epub 2019 Dec 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Antipruritics / pharmacology*
  • Antipruritics / therapeutic use
  • Dermatitis, Atopic / complications
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / pathology
  • Disease Models, Animal
  • Female
  • Humans
  • Janus Kinase Inhibitors / pharmacology*
  • Janus Kinase Inhibitors / therapeutic use
  • Male
  • Mice
  • Pruritus / drug therapy*
  • Pruritus / etiology
  • Pruritus / pathology
  • Pyrroles / pharmacology*
  • Pyrroles / therapeutic use
  • Skin / drug effects
  • Skin / innervation
  • Skin / pathology

Substances

  • Antipruritics
  • Janus Kinase Inhibitors
  • Pyrroles
  • delgocitinib